Dysregulation of the Epitranscriptomic Mark m(1)A in Ischemic Stroke

缺血性卒中中表观转录组标记m(1)A的失调

阅读:2

Abstract

Methylation of adenosine at N1 position yields N(1)-methyladenosine (m(1)A), which is an epitranscriptomic modification that regulates mRNA metabolism. Recent studies showed that altered m(1)A methylation promotes acute and chronic neurological diseases. We currently evaluated the effect of focal ischemia on cerebral m(1)A methylome and its machinery. Adult male C57BL/6J mice were subjected to transient middle cerebral artery occlusion, and the peri-infarct cortex was analyzed at 12 h and 24 h of reperfusion. The bulk abundance of m(1)A was measured by mass spectrometry and dot blot, and transcriptome-wide m(1)A alterations were profiled using antibody-independent m(1)A-quant-seq. Expression of the m(1)A writers and erasers was estimated by real-time PCR. Ischemia significantly decreased m(1)A levels and concomitantly upregulated m(1)A demethylase alkB homolog 3 at 24 h of reperfusion compared to sham. Transcriptome-wide profiling showed differential m(1)A methylation at 14 sites (8 were hypo- and 6 were hypermethylated). Many of those are located in the 3'-UTRs of unannotated transcripts proximal to the genes involved in regulating protein complex assembly, circadian rhythms, chromatin remodeling, and chromosome organization. Using several different approaches, we show for the first time that m(1)A epitranscriptomic modification in RNA is highly sensitive to cerebral ischemia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。